切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2011, Vol. 05 ›› Issue (02) : 189 -197. doi: 10.3877/cma.j.issn.1674-0807.2011.02.010

实验研究

RNA 干扰对MDA-MB-231 乳腺癌细胞株骨保护素基因表达的抑制作用
张帆1, 唐振宁1, 杨新华1, 徐琰1, 范林军1, 张毅1, 陈莉1, 周艳1, 陈庆秋1, 姜军1,()   
  1. 1.400038 重庆,第三军医大学西南医院乳腺疾病中心
  • 收稿日期:2010-05-11 出版日期:2011-04-01
  • 通信作者: 姜军
  • 基金资助:
    国家自然科学基金资助项目(30700814)第三军医大学2006年度中青年科研基金资助项目

Inhibitory effect of RNA interference on osteoprotegerin gene expression in MDA-MB-231 breast cancer cell line

Fan ZHANG1, Zhen-ning TANG1, Xin-hua YANG1, Yan XU1, Lin-jun FAN1, Yi ZHANG1, Li CHENG1, Yan ZHOU1, Qin-qiu CHEN1, Jun JIANG1,()   

  1. 1.Breast Disease Center, Southwest Hospital, Third Military Medical University , Chongqing 400038, China
  • Received:2010-05-11 Published:2011-04-01
  • Corresponding author: Jun JIANG
引用本文:

张帆, 唐振宁, 杨新华, 徐琰, 范林军, 张毅, 陈莉, 周艳, 陈庆秋, 姜军. RNA 干扰对MDA-MB-231 乳腺癌细胞株骨保护素基因表达的抑制作用[J/OL]. 中华乳腺病杂志(电子版), 2011, 05(02): 189-197.

Fan ZHANG, Zhen-ning TANG, Xin-hua YANG, Yan XU, Lin-jun FAN, Yi ZHANG, Li CHENG, Yan ZHOU, Qin-qiu CHEN, Jun JIANG. Inhibitory effect of RNA interference on osteoprotegerin gene expression in MDA-MB-231 breast cancer cell line[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2011, 05(02): 189-197.

目的

构建针对骨保护素(OPG)基因的一个载体编码三条短发夹RNA(shRNA)的真核表达质粒,观察其对MDA-MB-231 乳腺癌细胞株OPG 表达的抑制作用。

方法

选择3 个针对OPG 基因的RNA 干扰(RNAi)位点,分别设计合成3 对编码相应shRNA的DNA 单链,每对单链连接形成双链后分别与线性化载体pGenesil-1.1、pGenesil-1. 2、pGenesil-1. 3 连接形成pGenesil-1. 1-shRNA1、 pGenesil-1. 2-shRNA2、pGenesil-1.3-shRNA3,对以上重组载体反复酶切连接,构建成重组质pGenesil-1.1-1.2-1.3-shRNA1-shRNA2-shRNA3,酶切鉴定和测序无误后,将该质粒转染MDA-MB-231 细胞,以G418加压筛选,对转染细胞行单克隆化,稳定转染细胞行RT-PCR 和Western blot检测,确定其对OPG基因表达抑制作用。统计分析采用单因素方差分析和SLD分析法。

结果

成功构建了pGenesil-1.1-1.2-1.3-shRNA1-shRNA2-shRNA3 重组质粒;以该质粒稳定转染MDA-MB-231 细胞后其OPG mRNA和蛋白表达均较对照差异有统计学意义(P<0.05),RNAi对OPG mRNA和蛋白的表达抑制率分别为91%和73%。

结论

本研究构建了针对OPG 的一个载体编码3 条shRNA 的真核表达质粒,通过RNAi抑制了MDA-MB-231 细胞OPG 基因表达,为进一步深入探讨肿瘤细胞自身OPG 表达在乳腺癌骨转移发生发展中的作用提供了相关实验基础。

Objective

To construct a eukaryotic expression plasmid that expresses 3 shRNAs (short hairpin RNAs) targeting osteoprotegerin (OPG) gene and to investigate the inhibitory effect of RNA interference (RNAi) on osteoprotegerin gene expression in MDAMB-231 breast cancer cell line.

Methods

Three sites targeting osteoprotegerin gene were selected. Accordingly,three pairs of single stranded DNAs were designed,synthesized and annealed to double stranded DNAs. The double stranded DNAs were cloned into pGenesil-1.1,pGenesil-1. 2 and pGenesil-1. 3,respectively. After repeated enzyme digestion and ligation,the construction of recombinant plasmid pGenesil-1. 1-1. 2-1. 3-shRNA1-shRNA2-shRNA3 was completed. After identification of restriction endonuclease and sequencing,the recombinant plasmid was transfected into the MDA-MB-231 cells. After G418 screening,the stably transfected cells were identified with RT-PCR and Western blot. Statistical analysis was performed using One-way ANOVA and LSD methods.

Results

The eukaryotic expression plasmid pGenesil-1. 1-1. 2-1. 3-shRNA1-shRNA2-shRNA3 was constructed successfully. Compared with the control group,OPG mRNA and protein levels of MDA-MB-231 cells stably transfected with pGenesil-1. 1-1. 2-1. 3-shRNA1-shRNA2-shRNA3 were lower,with a statistically significant difference (P <0. 05). The inhibition rates of OPG mRNA and protein were 91% and 73%,respectively.

Conclusion

The eukaryotic expression plasmid that expresses 3 shRNAs targeting osteoprotegerin gene was constructed successfully,and the osteoprotegerin gene expression in MDA-MB-231 cells was inhibited by RNA interference in our study. Our study result may provide a basis for related experimental studies further exploring the role of OPG expression by tumor cell itself in the development and progression of breast cancer bone metastasis.

表1 shRNA转录模版DNA 序列
图1 SacI 酶切凝胶电泳鉴定 1、2、3:pGenesil-1.1-shRNA1;4:未酶切的pGenesil-1.2-shRNA2;5、6、7: pGenesil-1.2-shRNA2;9、10、11:pGenesil-1.3-shRNA3;8、16:标准
图2 MluI 和BamHI 双酶切凝胶电泳鉴定 1:标准;2:未酶切pGenesil-1.1-1.2-shRNA1-shRNA2;3、4、5:酶切pGenesil-1.1-1.2-shRNA1-shRNA2
图3 MluI 和EcoRI 双酶切凝胶电泳鉴定 1:标准;2、4、6:未酶切pGenesil-1.1-1.2-1.3-shRNA1-shRNA2-shRNA3;3、5、7:酶切pGenesil-1.1-1.2-1.3-shRNA1-shRNA2-shRNA3
图4 RT-PCR 检测OPG mRNA 表达 1:标准;2:C 组(对照MDA-MB-231 细胞);3:B 组(pGenesil-1.1-HK 质粒);4:A 组 (pGenesil-1.1-1.2-1.3-shRNA1-shRNA2-shRNA3);OPG:骨保护素;GAPDH:甘油醛-3-磷酸脱氢酶
图5 Western blot 检测OPG 蛋白表达 1:B 组(pGenesil-1.1-HK 质粒);2:A 组(pGenesil-1.1-1.2-1.3-shRNA1-shRNA2-shRNA3);3:C 组(对照MDA-MB-231 细胞) ;OPG:骨保护素;β-actin:β-肌动蛋白
[1]
Simonet WS,Lacey DL,Dunstan CR,et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density[J]. Cell,1997,89(2):309-319.
[2]
Thomas RJ,Guise TA,Yin JJ,et al. Breast cancer cells interact with osteoblasts to support osteoclast formation[J].Endocrinology,1999,140(10): 4451-4458.
[3]
Reid P,Holen I. Pathophysiological roles of osteoprotegerin (OPG)[J]. Eur J Cell Biol,2009,88(1):1-17.
[4]
Kozlow W,Guise TA. Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy[J]. J Mammary Gland Biol Neoplasia,2005,10(2): 169-180.
[5]
Holen I,Cross SS,Neville-Webbe HL,et al. Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival? [J]. Breast Cancer Res Treat,2005,92(3): 207-215.
[6]
李银鹏,朱惠明,侯晓华. 靶向mcl-1基因的shRNA 真核表达质粒的构建与筛选[J]. 世界华人消化杂志,2008,16(26): 2490-2495.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[6] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[7] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[8] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[9] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[10] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
阅读次数
全文


摘要